Product NDC: | 10019-178 |
Proprietary Name: | Morphine Sulfate |
Non Proprietary Name: | Morphine Sulfate |
Active Ingredient(s): | 10 mg/mL & nbsp; Morphine Sulfate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-178 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20100526 |
Package NDC: | 10019-178-68 |
Package Description: | 25 AMPULE in 1 BOX (10019-178-68) > 1 mL in 1 AMPULE (10019-178-37) |
NDC Code | 10019-178-68 |
Proprietary Name | Morphine Sulfate |
Package Description | 25 AMPULE in 1 BOX (10019-178-68) > 1 mL in 1 AMPULE (10019-178-37) |
Product NDC | 10019-178 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Morphine Sulfate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20100526 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | MORPHINE SULFATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |